HANDLING OF THALIDOMIDE PREPARATION AND ITS DERIVATIVES IN JAPAN AND OUR HOSPITAL'S EFFORTS
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-112
- By: SATO, Mikako (National Hospital Organization Disaster Medical Center, Japan)
- Co-author(s): Mikako Sato: pharmacy, National Hospital Organization Disaster Medical Center, Japan
Multiple myeloma is still incurable disease, however, novel agents have improved the prognosis. Among of them, Immunomodulatory drugs, ImiDs (i.e., Thalidomide, lenalidomide, and pomalidomide) are fundamental drugs for several treatment regimens. ImiDs are thalidomide formulations or thalidomide derivative formulations and are known to The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019